Search

Search Constraints

You searched for: Author/Creator Gao, Yuhuan

Search Results

2. Comparison of efficacy and safety of ripertamab (SCT400) versus rituximab (Mabthera®) in combination with CHOP in patients with previously untreated CD20‐positive diffuse large B‐cell lymphoma: A randomized, single‐blind, phase III clinical trial. Issue 5 (12th August 2022)

5. Primary breast diffuse large B‐cell lymphoma in the rituximab era: Therapeutic strategies and patterns of failure. Issue 12 (11th November 2018)

7. Rituximab plus chemotherapy as first-line treatment in Chinese patients with diffuse large B-cell lymphoma in routine practice: a prospective, multicentre, non-interventional study. Issue 1 (December 2016)

8. Safety and activity of sintilimab in patients with relapsed or refractory classical Hodgkin lymphoma (ORIENT-1): a multicentre, single-arm, phase 2 trial. Issue 1 (January 2019)

10. Targeted sequencing reveals the relationship between mutations and patients' clinical indicators, blood cell counts and early progression in diffuse large-B cell lymphoma. Issue 1 (2nd January 2023)